immunooncologyindia.com
Jul 4, 2025, 03:04
Herbert Loong: The Prevalence and Prognostic Impact of Comorbidities and Bloodindices in Sarcomas
Herbert Loong, Chair-Elect of the International Affairs Committee and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO), shared a post on LinkedIn:
“Happy to throwback 5 years ago when we published our work looking at the prevalence and prognostic impact of comorbidities and bloodindices in sarcomas.
This was based on a 4000+ patients’ dataset from HongKong.”
More posts featuring Herbert Loong on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 26, 2025, 06:11
Jul 26, 2025, 04:02
Jul 26, 2025, 03:52
Jul 26, 2025, 03:45
Jul 26, 2025, 03:33
Jul 25, 2025, 22:02
Jul 25, 2025, 21:34
Jul 25, 2025, 21:01
Jul 25, 2025, 20:41